SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,055,000 | -81.2% | 290,983 | -77.2% | 0.03% | -82.1% |
| Q1 2017 | $80,065,000 | -30.5% | 1,273,698 | -41.7% | 0.16% | -34.7% |
| Q4 2016 | $115,195,000 | -48.0% | 2,182,971 | -46.8% | 0.24% | -45.8% |
| Q3 2016 | $221,675,000 | +30.4% | 4,104,329 | -2.4% | 0.44% | +22.2% |
| Q2 2016 | $169,969,000 | +10.8% | 4,206,104 | -3.8% | 0.36% | +13.2% |
| Q1 2016 | $153,426,000 | -22.0% | 4,372,346 | -0.2% | 0.32% | -17.6% |
| Q4 2015 | $196,667,000 | +47.1% | 4,382,053 | +26.4% | 0.39% | +42.3% |
| Q3 2015 | $133,692,000 | +38.0% | 3,467,125 | +73.2% | 0.27% | +52.0% |
| Q2 2015 | $96,905,000 | – | 2,002,164 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |